BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-7 out of 7 found
  Current Search:  prednisone: 7     
HTML
100%
Clinical Trial Watch
Sunitinib Plus Prednisone In Patients With Metastatic Hormone-Refractory Prostate Cancer After Failure Of Docetaxel Chemotherapy Sponsor(s): Pfizer Identifier: NCT00676650 Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in...
Modern Medicine:  Feb 5 2010 4:59AM
Matching: prednisone 		Find similar documents
HTML
100%
Survival data on Bortezomib label
Data showing a 35 per cent improvement in long-term overall survival when patients with multiple myeloma are treated with bortezomib as initial therapy have been added to the prescribing information for the drug, according to the manufacturer.

Millennium: The...

Irish Medical News:  Jan 23 2010 11:24PM
Matching: prednisone 		Find similar documents
HTML
100%
Majestic Research Finds Hematologists/Oncologists Expect To Change Multiple Myeloma Treatment Practices Due To
In a study published by Majestic Research's Market Research Group (formerly Rood Research), it was found that many hematologists and oncologists who attended the American Society of Hematology (ASH) 2009 Annual Meeting expect to change their multiple myeloma...
Medical News Today:  Jan 15 2010 11:26PM
Matching: prednisone 		Find similar documents
HTML
100%
Majestic Research Finds Hematologists/Oncologists Expect to Change Multiple Myeloma Treatment Practices Due to
- In a study published by Majestic Research's (formerly Rood Research), it was found that many hematologists and oncologists who attended the American Society of Hematology (ASH) 2009 Annual Meeting expect to change their multiple myeloma treatment practices,...
Pharma Live:  Jan 14 2010 11:19PM
Matching: prednisone 		Find similar documents
HTML
100%
Advances in Optimizing Therapy and Quality of Life for People With Hard-to-Treat Blood Cancers
Research presented at the 51st Annual ASH Meeting explored optimal induction therapies for managing multiple myeloma and a potential first-line therapy for patients with non-Hodgkin lymphoma (NHL).

Studies such as these are designed to improve the quality of...

Cancernetwork.com:  Jan 14 2010 10:25PM
Matching: prednisone 		Find similar documents
HTML
100%
Majestic Research Finds Hematologists/Oncologists Expect to Change Multiple Myeloma Treatment Practices Due to ASH 2009 Data
NEW YORK--(BUSINESS WIRE)--In a study published by Majestic Research?s (formerly Rood Research), it was found that many hematologists and oncologists who attended the American Society of Hematology (ASH) 2009 Annual Meeting expect to change their multiple...
Yahoo! Canada:  Jan 14 2010 4:47PM
Matching: prednisone 		Find similar documents
HTML
100%
Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves' Orbitopathy: A Retrospective Cohort Study
Lai A et al.

Lower doses of oral prednisone (about 0.2 mg/kg bw) are as effective as previously reported doses (0.30.5 mg/kg bw).

Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves' Orbitopathy: A...

MDLinx:  Jan 14 2010 10:23AM
Matching: prednisone 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.